System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Matthew B Schabath is an expert in Oncology at Moffitt Cancer Center (United States). As of October 2026, ScienceLeadR ranks Matthew B Schabath in the top 1% of experts worldwide for Lung Neoplasms and Thoracic Neoplasms. Matthew B Schabath has authored 409 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 1,329 (community average: 125). How the SLR is computed.

LeadR Profile

Matthew B Schabath Moffitt Cancer Center United States
1 329 ScienceLeadR Reputation 1329

Unlock

Register Login
Network Map

Oncology

Subspecialties: Public Health - Pulmonology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

Moffitt Cancer Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 409

Citations

Citations: 18 682 1st author: 43 Last author: 77 Unique author: 3

Main journals

Cancer Res 43
J Thorac Oncol 27
Cancer Epidemiol Biomarkers Prev 26
J Clin Oncol 16
medRxiv 12

Best Journals

J Clin Oncol 13
Nature 3
CA Cancer J Clin 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Foundation Models and Multimodal Learning for Medical Data with Applications in Oncology.
PMID 42870148 — pathology, foundations, learning		J Imaging Inform Med20260
Predictors of anal and cervical cancer screening uptake among adults with and without HIV: survey of a community-based health clinic network.
PMID 42714682 — comorbidity, anus neoplasms, uterine cervical neoplasms, neoplasms		Cancer Causes Control20260
Multidimensional LDCT Imaging Endpoints for a Randomized Pilot Phase II Trial of Curcumin and Omega-3 Fatty Acids for Lung Cancer Chemoprevention: Results of a Randomized Pilot Trial.
PMID 42649879 — pilot projects, pilots, lung, biological availability, safety, fatty acids, omega-3, smokers, neoplasms, chemoprevention, biomarkers, lung neoplasms, curcumin, therapeutics, fatty acids		Cancers (Basel)20260
Author Correction: Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma.
PMID 42581169 — lung, adenocarcinoma, adenocarcinoma of lung		Nature Top journal20260
The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum.
PMID 42583877 — treatment outcome, early diagnosis, lung, early detection of cancer, neoplasms, continuity of patient care, diagnostic imaging, lung neoplasms, diagnosis		Cancer20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Not yet recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals
NCT06844097 — disasters, research design, education, medical, uterine cervical neoplasms, neoplasms, research, education, clinical competence, men		N/ANot yet recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS